Frilling A, Åkerström G, Falconi M, Pavel M, Ramos J, Kidd M, Modlin IM (2012) Neuroendocrine tumor disease: an evolving landscape. Endocr Relat Cancer 19:163–185. https://doi.org/10.1530/ERC-12-0024

CAS  Article  Google Scholar 

Scandurra C, Modica R, Maldonato NM, Dolce P, Dipietrangelo GG, Centello R, di Vito V, Bottiglieri F, de Cicco F, Giannetta E, Isidori AM, Lenzi A, Muzii B, Faggiano A, Colao A (2021) Quality of life in patients with neuroendocrine neoplasms: the role of severity, clinical heterogeneity, and resilience. J Clin Endocrinol Metab 106:e316–e327. https://doi.org/10.1210/clinem/dgaa760

Article  PubMed  Google Scholar 

Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih T, Yao JC (2017) Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 3:1335–1342. https://doi.org/10.1001/jamaoncol.2017.0589

Article  PubMed  PubMed Central  Google Scholar 

Das S, Dasari A (2021) Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences? Curr Oncol Rep 23:43. https://doi.org/10.1007/s11912-021-01029-7

Article  PubMed  PubMed Central  Google Scholar 

Faggiano A, lo Calzo F, Pizza G, Modica R, Colao A, (2017) The safety of available treatments options for neuroendocrine tumors. Expert Opin Drug Saf 16:1149–1161. https://doi.org/10.1080/14740338.2017.1354984

CAS  Article  PubMed  Google Scholar 

Faggiano A, di Maio S, Mocerino C, Ottaviano M, de Divitiis C, Guarnotta V, Dolce P, Modica R, Puliafito I, Tozzi L, di Sarno A, Leo S, Riccardi F, Palmieri G, Tafuto S, Bianco A, Badalamenti G, Colao A (2019) Therapeutic sequences in patients with grade 1–2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group. Endocrine 66:417–424. https://doi.org/10.1007/s12020-019-01894-0

CAS  Article  PubMed  Google Scholar 

Beesley VL, Burge M, Dumbrava M, Callum J, Neale RE, Wyld DK (2018) Perceptions of care and patient-reported outcomes in people living with neuroendocrine tumours. Supp Care Cancer 26:3153–3161. https://doi.org/10.1007/s00520-018-4166-5

Article  Google Scholar 

Firkins J, Hansen L, Driessnack M, Dieckmann N (2020) Quality of life in “chronic” cancer survivors: a meta-analysis. J Cancer Surviv 14:504–517. https://doi.org/10.1007/s11764-020-00869-9

Article  PubMed  Google Scholar 

Jiménez-Fonseca P, Carmona-Bayonas A, Martín-Pérez E, Crespo G, Serrano R, Llanos M, Villabona C, García-Carbonero R, Aller J, Capdevila J, Grande E (2015) Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors. Cancer Metastasis Rev 34:381–400. https://doi.org/10.1007/s10555-015-9573-1

CAS  Article  PubMed  Google Scholar 

Haugland T, Devon HA (2019) Symptoms, psychosocial factors, and health-related quality of life in patients with neuroendocrine tumors: An integrative review. Cancer Nurs 42:E36–E46. https://doi.org/10.1097/NCC.0000000000000614

Article  PubMed  Google Scholar 

White BE, Druce MR, Grozinsky-Glasberg S, Srirajaskanthan R, Gamper EM, Gray D, Mujica-Mota R, Ramage JK (2020) Health-related quality of life in neuroendocrine neoplasia: a critical review. Endocr Relat Cancer 27:R267–R280. https://doi.org/10.1530/ERC-20-0066

CAS  Article  PubMed  Google Scholar 

Martini C, Gamper EM, Wintner L, Nilica B, Sperner-Unterweger B, Holzner B, Virgolini I (2016) Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumours. Health Qual Life Outcomes 14:127. https://doi.org/10.1186/s12955-016-0527-2

Article  PubMed  PubMed Central  Google Scholar 

Hallet J, Davis LE, Mahar AL, Isenberg-Grzeda E, Bubis LD, Myrehaug S, Zhao H, Beyfuss K, Moody L, Law CHL, Coburn NG (2019) Symptom burden at the end of life for neuroendocrine tumors: an analysis of 2579 prospectively collected patient-reported outcomes. Ann Surg Oncol 26:2711–2721. https://doi.org/10.1245/s10434-019-07441-5

Article  PubMed  Google Scholar 

Martini C, Buxbaum S, Rodrigues M, Nilica B, Scarpa L, Holzner B, Virgolini I, Gamper EM (2018) Quality of life in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy: information from a monitoring program in clinical routine. J Nucl Med 59:1566–1573. https://doi.org/10.2967/jnumed.117.204834

CAS  Article  PubMed  Google Scholar 

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, Haes JCJMD, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376. https://doi.org/10.1093/jnci/85.5.365

CAS  Article  PubMed  Google Scholar 

Hjemdal O, Friborg O, Braun S, Kempenaers C, Linkowski P, Fossion P (2011) The resilience scale for adults: construct validity and measurement in a Belgian sample. Int J Test 11:53–70. https://doi.org/10.1080/15305058.2010.508570

Article  Google Scholar 

Bates D, Mächler M, Bolker BM, Walker SC (2015) Fitting linear mixed-effects models using lme4. J Stat Softw 67:1–48

Article  Google Scholar 

Eicher M, Matzka M, Dubey C, White K (2015) Resilience in adult cancer care: an integrative literature review. Oncol Nurs Forum 42:E3-16. https://doi.org/10.1188/15.ONF.E3-E16

Article  PubMed  Google Scholar 

Matzka M, Mayer H, Köck-Hódi S, Moses-Passini C, Dubey C, Jahn P, Schneeweiss S, Eicher M (2016) Relationship between resilience, psychological distress and physical activity in cancer patients: a cross-sectional observation study. PLoS ONE 11:e0154496. https://doi.org/10.1371/journal.pone.0154496

CAS  Article  PubMed  PubMed Central  Google Scholar 

Ristevska-Dimitrovska G, Filov I, Rajchanovska D, Stefanovski P, Dejanova B (2015) Resilience and quality of life in breast cancer patients. Open Access Maced J Med Sci 3:727–731. https://doi.org/10.3889/oamjms.2015.128

Article  PubMed  PubMed Central  Google Scholar 

Clarke G, Asiedu YA, Herd K, Sharma S (2019) Exploring the relation between patients’ resilience and quality of life after treatment for cancer of the head and neck. Br J Oral Maxillofac Surg 57:1044–1048. https://doi.org/10.1016/j.bjoms.2019.09.007

CAS  Article  PubMed  Google Scholar 

Li X, Chen S, Zhang J, Li L, Li Y, Ye M (2021) Resilience process and its protective factors in long-term survivors after lung cancer surgery: a qualitative study. Supp Care Cancer 29:1455–1463. https://doi.org/10.1007/s00520-020-05633-4

Article  Google Scholar 

Thong MSY, van Noorden CJF, Steindorf K, Arndt V (2020) Cancer-related fatigue: Causes and current treatment options. Curr Treat Options Oncol 21:17. https://doi.org/10.1007/s11864-020-0707-5

Article  PubMed  PubMed Central  Google Scholar 

Pearman TP, Beaumont JL, Cella D, Neary MP, Yao J (2016) Health-related quality of life in patients with neuroendocrine tumors: an investigation of treatment type, disease status, and symptom burden. Supp Care Cancer 24:3695–3703. https://doi.org/10.1007/s00520-016-3189-z

Article  Google Scholar 

Walter T (2017) Maintaining quality of life for patients with neuroendocrine tumours. Lancet Oncol 18:1299–1300. https://doi.org/10.1016/S1470-2045(17)30618-6

Article  PubMed  Google Scholar 

Faggiano A, Modica R, Calzo F, Camera L, Napolitano V, Altieri B, de Cicco F, Bottiglieri F, Sesti F, Badalamenti G, Isidori AM, Colao A (2019) Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors 2 centimeters. J Clin Endocrinol Metab 105:007

Google Scholar 

Rossi R, Jannini TB, Socci V, Pacitti F, Lorenzo G (2021) Stressful life events and resilience during the COVID-19 lockdown measures in Italy: Association with mental health outcomes and age. Front Psychiatry 12:635832. https://doi.org/10.3389/fpsyt.2021.635832

Article  PubMed  PubMed Central  Google Scholar 

Panzuto F, Maccauro M, Campana D, Faggiano A, Massironi S, Pusceddu S, Spada F, Ferone D, Modica R, Grana CM, Ferolla P, Rinzivillo M, Badalamenti G, Zatelli MC, Gelsomino F, de Carlo E, Bartolomei M, Brizzi MP, Cingarlini S, Versari A, Fanciulli G, Arvat E, Merola E, Cives M, Tafuto S, Baldari S, Falconi M (2021) Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet). J Endocrinol Investig 44:989–994. https://doi.org/10.1007/s40618-020-01393-4

CAS  Article  Google Scholar 

Massironi S, Campana D, Pusceddu S, Albertelli M, Faggiano A, Panzuto F, Smiroldo V, Andreasi V, Rossi RE, Maggio I, Torchio M, Dotto A, Modica R, Rinzivillo M, Carnaghi C, Partelli S, Fanetti I, Lamberti G, Corti F, Ferone D, Colao A, Annibale B, Invernizzi P, Falconi M, ItaNet (Italian Association for Neuroendocrine Tumours) (2021) Study Group. Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study. Dig Liver Dis 53:367–374. https://doi.org/10.1016/j.dld.2020.09.031

CAS  Article  PubMed  Google Scholar